Biltmore Family Office’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,378
Closed -$212K 272
2024
Q3
$212K Buy
+3,378
New +$197K 0.04% 200
2020
Q3
Sell
-5,805
Closed -$377K 172
2020
Q2
$377K Hold
5,805
0.23% 95
2020
Q1
$344K Buy
5,805
+24
+0.4% +$1.6K 0.23% 103
2019
Q4
$429K Buy
5,781
+91
+2% +$6.39K 0.17% 111
2019
Q3
$359K Hold
5,690
0.16% 116
2019
Q2
$310K Sell
5,690
-415
-7% -$22.3K 0.17% 109
2019
Q1
$329K Sell
6,105
-1,131
-16% -$69.8K 0.17% 113
2018
Q4
$474K Buy
7,236
+747
+12% +$55.8K 0.27% 88
2018
Q3
$511K Hold
6,489
0.24% 93
2018
Q2
$418K Sell
6,489
-2,115
-25% -$139K 0.21% 96
2018
Q1
$535K Buy
8,604
+1,500
+21% +$108K 0.24% 98
2017
Q4
$515K Buy
+7,104
New +$516K 0.23% 95

Other funds holding CVS

Biltmore Family Office's CVS Position: Q4 2024 in Review

Biltmore Family Office sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,378 shares — an estimated $212K sold.

Biltmore Family Office first reported a position in CVS in Q4 2017 and held it in 12 quarters. The position peaked at $535K in Q1 2018. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Biltmore Family Office reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Biltmore Family Office sold 3,378 CVS Health shares in Q4 2024, an estimated $212K.
  • Biltmore Family Office first reported a position in CVS Health in Q4 2017 and held it in 12 quarters.
  • Biltmore Family Office's CVS Health position peaked at $535K in Q1 2018.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Biltmore Family Office's 13F filing for Q4 2024, filed 12 Feb 2025.